Results 41 to 50 of about 13,126,675 (165)
Deep Dermatophytosis Associated With Inherited CARD9 Deficiency: Efficacy of Topical 1% Voriconazole
JEADV Clinical Practice, EarlyView.ABSTRACT Deep dermatophytosis (DD) is a rare, life‐threatening fungal infection associated with autosomal recessive CARD9 deficiency. Management remains challenging, as systemic antifungals often fail to achieve lasting control. A 54‐year‐old man with a 20‐year history of ulcerative skin lesions and confirmed CARD9 deficiency (Q289X/Q289X) presented ...
Sarah Milesi +6 more
wiley +1 more source
Efficacy of aerosolized liposomal amphotericin B against murine invasive pulmonary mucormycosis [PDF]
, 2014 Invasive pulmonary mucormycosis is a life-threatening fungal infection encountered in immunocompromised patients. An intravenous high-dose lipid formulation of amphotericin B, such as liposomal amphotericin B (L-AMB), is the recommended treatment.
Kakeya, Hiroshi +17 more
core +1 more source
Asia-Pacific Journal of Clinical Oncology, EarlyView.We report our single‐center experience of transplant outcomes with a busulfan, fludarabine and melphalan‐based conditioning regimen for children < 18 years of age. The regimen was shown to be well tolerated and effective for heavily pretreated children with high‐risk myeloid malignancies prior to allogeneic hematopoietic stem cell transplant.
Mayank Dhamija +6 more
wiley +1 more source
A difficult-to-treat pleuropulmonary histoplasmosis in a patient with rheumatoid arthritis in Taiwan
Journal of Microbiology, Immunology and Infection, 2023 Amphotericin B and itraconazole are the primary agents for treating histoplasmosis. Newer azoles are alternatives for patients refractory to or intolerant of standard therapy.
Wen-Kai Chu +6 more
doaj +1 more source
Internal Medicine Journal, EarlyView.Abstract Chimeric antigen receptor (CAR) T‐cell therapies directed against cluster of differentiation 19 (CD19) are a standard of care for relapsed or refractory B‐cell lymphomas. Infection is the leading cause of non‐relapse mortality, and this risk may persist for years after CAR T‐cell receipt.
Aine Hurley +15 more
wiley +1 more source
Medical Mycology Case Reports, 2018 We encountered a case of a 73-year-old man with acute myeloid leukemia who developed Trichosporon asahii systemic infection while on itraconazole prophylaxis during severe neutropenia. Cryptococcal antigen was useful for diagnosis.
Daiki Karigane +6 more
doaj +1 more source
Systemic treatment of cutaneous leishmaniasis: A systematic review and meta‐analysis
Journal of the European Academy of Dermatology and Venereology, EarlyView.This systematic review and meta‐analysis assessed systemic treatments for cutaneous leishmaniasis across 83 studies and 4603 patients. Treatment efficacies of meglumine antimoniate, miltefosine, azoles, pentamidine, and liposomal amphotericin B varied by region and species. Miltefosine showed consistent evidence across multiple settings.
Maximilian Egg +10 more
wiley +1 more source
Precision MedicationBackground: Fungal infections have emerged as an increasingly serious public health challenge globally. Four Formulations of amphotericin B are widely used in antifungal therapy.
Shuai Liu +7 more
doaj +1 more source
Rhinocerebral zygomycosis treated with liposomal amphotericin B and surgery
, 2021 We report three cases with rhinocerebral zygomycosis in two diabetic persons and one otherwise healthy person. The diagnosis was established by histopathological appearance and computerized tomography (CT) and/or magnetic resonance imaging (MRI) scans ...
Dundar, IH +3 more
core +2 more sources
Hematological Oncology, Volume 44, Issue 6, November 2026.ABSTRACT In recent years the addition of the oral BCL2 inhibitor venetoclax to hypomethylating agents (HMAs) has emerged as the standard‐of‐care for patients with acute myeloid leukemia (AML) who are not fit for intensive chemotherapy, significantly improving survival and quality‐of‐life.
Mariarita Sciumè +9 more
wiley +1 more source